![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, February 27, 2021 9:14:42 PM
"As of January 31, 2021, we had outstanding (i) 18,849,983 shares of common stock, and (ii) 31,476.98412 shares of Series B-2 Preferred Stock."
"As of January 31, 2021, we had outstanding warrants to purchase up to 14,360,807 shares of our common stock at a weighted average exercise price of $7.31 per share and which expire between October 24, 2023 and January 26, 2026. The warrants include a net exercise provision and contain provisions for the adjustment of the exercise price and the number of shares issuable upon the exercise of each warrant in the event of certain stock dividends, stock splits, reorganizations, reclassifications and consolidations."
At June 30, 2020 KemPharm also had $67,271,000 outstanding convertible debt with the following conversion price:
"In connection with entering into the January 2020 Exchange Agreement, the Company entered into an Amendment to Facility Agreement and December 2019 Notes and Consent (the "December 2019 Note Amendment") with the December 2019 Holders that, among other things, (i) amended the December 2019 Notes to (a) reduce the Conversion Price (as defined in the December 2019 Notes) from $17.11 to $5.85 per share"
I could not find more current information on the convertible debt, especially what happened to their conversion rights after the reverse split, but it is still a red flag issue, along with the warrants.
For example, the short sale positions in the stock could easily be the convertible debt holders already selling at "good prices". If so, these short sales cannot be "squeezed" by higher price levels. The bond holders instead would simply convert the debt into new stock shares and provide these shares to cover any borrowed shares (which they may not even have had to do legally, since they had access to the new shares). So no squeeze.
The same could be true for current warrant holders, who may also have sold stock short recently, because current prices are higher than their conversion price. So no squeeze.
Buyer beware.
Recent KMPH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/25/2024 09:13:10 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/25/2024 09:11:32 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2024 11:49:38 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/10/2024 08:23:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2024 11:46:20 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/03/2024 08:17:44 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/03/2024 08:15:21 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/01/2024 09:27:49 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM